As part of San Francisco Litquake festival, Sonia Arrison, author of 100 Plus, David Ewing Duncan, writer of When I'm 164, join the great futurist Paul Saffo to discuss what happens to humans if the science of anti-aging succeeds.
Sonia Arrison is a technology analyst and bestselling author of 100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith. She is a founder and trustee of Singularity University.
David Ewing Duncan
David Ewing Duncan is an award-winning, best-selling author of six books and numerous essays, articles and short stories, and a television, radio and film producer and correspondent. He is the co-host of NPR's Biotech Nation.
Duncan's most recent book is Experimental Man: What one man’s body reveals about his future, your health, and our toxic world (John Wiley). His last book was Masterminds: Genius, DNA and the Quest to Rewrite Life (Harper Perennial). He also wrote the international bestseller Calendar: Humanity's Epic Struggle to Determine a True and Accurate Year (Harper-Collins/Avon), published in 19 languages, and a bestseller in 14 countries.
Duncan is a Contributing Editor to Wired, and Discover, and a science columnist for the San Francisco Chronicle, a commentator for NPR's Morning Edition and co-host of BioTech Nation on NPR. He has been a special correspondent and producer for ABC's Nightline and 20/20, and a producer for Discovery Television. He is a correspondent for NOVA's ScienceNow!. He is a regular contributor to National Geographic, Fortune and MIT Technology Review, and was a longtime correspondent for Life.
He also writes for Harper's, Atlantic Monthly, Smithsonian, Outside, The Telegraph, The Guardian, The Washington Post Book World, and The New York Times, among others. He contributes to the Dialogues column for Discover.
Paul Saffo is a forecaster and strategist with over two decades experience exploring long-term technological change and its practical impact on business and society. He was initiated into the Ancient and Honorable Order of E Clampus Vitus in 2000 and is chairman of the Most Important Committee.
Saffo is Chairman of the Samsung Science Board, and serves on a variety of other boards and advisory panels, including the Stanford Advisory Council on Science, Technology and Society, and the Long Now Foundation, as well as the boards of several public and pre-public companies located the United States and abroad. He is also a Fellow of the Royal Swedish Academy of Engineering Sciences and has served as an advisor and Forum Fellow to the World Economic Forum, which in the late 1990s named Saffo one of its "100 Global Leaders For Tomorrow."
David Ewing Duncan, author of When I'm 164, questions the benefits of living to an advanced age. Despite medical advancement that promise greater expectancy and wellness, Duncan shares that many seniors do not wish to live to extreme ages.
Technology forecaster Paul Saffo ponders whether advancements in science and medicine would compel society to lengthen the lives of the world's greatest geniuses. Saffo also discusses the influence of people who bloomed later in life.